Validation of Ultrasonic Positive Diagnosis Criteria of Ipsilateral Deep Vein Thrombosis Recurrence of the Lower Limbs Based on Thrombosis Evolution at a 3-month Follow-up Under Anticoagulation: The ULTREC Project Ancillary Study (ULTRECAncillar)

  • days left to enroll
  • participants needed
  • sponsor
    Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Updated on 24 October 2022
deep vein thrombosis
doppler ultrasound
deep venous thrombosis of lower extremity


The ULTREC research project is designed to assess the safety of a negative strategy relying on Colour Doppler Ultrasound (CDUS) for excluding the diagnosis of a new thrombosis. The ULTREC project does not take into account the validity of the CDUS positive criteria used to confirm the diagnosis of Deep Vein Thrombosis (DVT) recurrence.

The risk of considering only the negative strategy is to ignore the possibility of having an improvement in sensitivity and negative predictive value at the expense of specificity and positive predictive value and therefore to increase the false positive rate leading to an overdiagnosis of recurrence and an overtreatment, and a potential bleeding risk.

In the ULTREC-ANCILLARY study, the research will aim at assessing the validity of baseline CDUS positive criteria for the diagnosis of DVT recurrence. As there is no diagnostic standard to which the results could be compared, it is suggested to validate these criteria based on the evolution of the thrombosis on CDUS performed at D90±5.

The hypothesis is that an unchanged appearance under anticoagulation would be in favor of sequelae and will invalidate the initial diagnosis (diagnostic failure)

Condition Deep Vein Thrombosis
Treatment color Doppler ultrasound
Clinical Study IdentifierNCT05300139
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Last Modified on24 October 2022


Yes No Not Sure

Inclusion Criteria

Age ≥ 18 years
Known history of objectively documented deep vein thrombosis of the lower limb (with or without pulmonary embolism)
Out-patients referred for clinically suspected acute recurrent ipsilateral DVT of the lower limb
Patients covered by social security or an equivalent regimen
No objection to the use of the data
Inclusion in the ULTREC study

Exclusion Criteria

Known current pregnancy
Any condition, which may prevent from performing the colour doppler ultrasound test
Delay from onset of symptoms to inclusion of more than 10 days
Therapeutic anticoagulation for more than 48 hours in the two days prior to consent to ULTREC Study
Presence of clinical symptoms or signs of pulmonary embolism
Life expectancy less than 3 months
Patient unable to adhere to ULTREC protocol follow-up
Participants under judicial protection or incapacity
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note